Human papillomavirus vaccines: organisation and experience of preclinical studies

INTRODUCTION. Vaccination is the main measure for the primary prevention of human papillomavirus (HPV)-related diseases. The development of novel vaccine candidates is underway worldwide, including in the Russian Federation. At the same time, the clinical introduction of new HPV vaccines is seriousl...

Descripció completa

Dades bibliogràfiques

Autors principals:	A. S. Korovkin, T. N. Nikitina, T. Yu. Kozlova, D. V. Gorenkov, A. R. Volgin
Format:	Artigo
Idioma:	Russo
Publicat:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Col·lecció:	Биопрепараты: Профилактика, диагностика, лечение
Matèries:	papillomavirus vaccines papillomavirus infections hpv vaccines vaccination capsid proteins l1 protein adjuvants hpv serotypes animals preclinical studies
Accés en línia:	https://www.biopreparations.ru/jour/article/view/589
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!